To create a strategy for inducible gene targeting we developed a Cre-l
ox recombination system which responds to the synthetic steroid RU 486
. Several fusions between Cre recombinase and the hormone binding doma
in (HBD) of a mutated human progesterone receptor, which binds RU 486
but not progesterone, were constructed. When tested in transient expre
ssion assays recombination activities of all fusion proteins were resp
onsive to RU 486, but not to the endogenous steroid progesterone. Howe
ver, the observed induction of recombination activity by the synthetic
steroid varied between the different fusion proteins. The fusion with
the highest activity in the presence of RU 486 combined with low back
ground activity in the absence of the steroid was tested after stable
expression in fibroblast and embryonal stem (ES) cells. We could demon
strate that its recombination activity was highly dependent on RU 486.
Since the RU 486 doses required to activate recombination were consid
erably lower than doses displaying anti-progesterone effects in mice,
this system could be used as a valuable tool for inducible gene target
ing.